CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range
- PMID: 7490758
- DOI: 10.1006/jmbi.1995.0626
CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range
Abstract
We describe the investigation of methodologies for the creation of very high affinity human antibodies. The high affinity human antibody b4/12 was optimized for its affinity to the human envelope glycoprotein gp120 of human immunodeficiency virus type 1 (HIV-1). Five libraries of b4/12 were constructed by saturation mutagenesis of complementarity-determining regions (CDRs). Libraries of antibody Fab fragments were displayed on the surface of filamentous phage and selected in vitro for binding to immobilized gp120. Sequential and parallel optimization strategies of CDRs were examined. The sequential CDR walking strategy consistently yielded b4/12 variants of improved affinity in each of the four different optimization sequences examined. This resulted in a 96-fold improvement in affinity. Additivity effects in the antibody combining site were explored by combining independently optimized CDRs in the parallel optimization strategy. Six variants containing optimized CDRs were constructed. Improvement of affinity based on additivity effects proved to be unpredictable but did lead to a modest improvement in affinity. Indeed, only one of the six combinations demonstrated additivity. The highest affinity Fab prepared using this strategy was improved 420-fold in affinity. The affinity of this Fab was 15 pM as compared to 6.3 nM for b4/12. Examination of the kinetics of Fab binding to gp120 revealed that improvements in affinity were dominated by a slowing of the off-rate of the Fab. The methodology presented here provides a route for the improvement of the affinities of antibodies typical of tertiary immune responses into the picomolar range. Such improvements may have profound effects on the utility of antibodies as therapeutic and prophylactic agents.
Similar articles
-
Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.J Mol Biol. 1996 Feb 16;256(1):77-88. doi: 10.1006/jmbi.1996.0069. J Mol Biol. 1996. PMID: 8609615
-
Improvement in affinity and HIV-1 neutralization by somatic mutation in the heavy chain first complementarity-determining region of antibodies triggered by HIV-1 infection.Eur J Immunol. 2001 Jan;31(1):128-37. doi: 10.1002/1521-4141(200101)31:1<128::aid-immu128>3.0.co;2-t. Eur J Immunol. 2001. PMID: 11169446
-
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.Science. 2003 Jun 27;300(5628):2065-71. doi: 10.1126/science.1083182. Science. 2003. PMID: 12829775
-
Selection and evolution of high-affinity human anti-viral antibodies.Trends Biotechnol. 1996 Jul;14(7):230-4. doi: 10.1016/0167-7799(96)10029-9. Trends Biotechnol. 1996. PMID: 8771795 Review.
-
Antibodies against HIV-1 from phage display libraries: mapping of an immune response and progress towards antiviral immunotherapy.Chem Immunol. 1997;65:18-56. doi: 10.1159/000319346. Chem Immunol. 1997. PMID: 9018871 Review. No abstract available.
Cited by
-
Directed evolution of anti-HER2 DARPins by SNAP display reveals stability/function trade-offs in the selection process.Protein Eng Des Sel. 2015 Sep;28(9):269-79. doi: 10.1093/protein/gzv029. Epub 2015 Jun 30. Protein Eng Des Sel. 2015. PMID: 26134501 Free PMC article.
-
Combining Yeast Display and Competitive FACS to Select Rare Hapten-Specific Clones from Recombinant Antibody Libraries.Anal Chem. 2016 Sep 20;88(18):9181-9. doi: 10.1021/acs.analchem.6b02334. Epub 2016 Sep 8. Anal Chem. 2016. PMID: 27571429 Free PMC article.
-
Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans.Nat Commun. 2016 Apr 19;7:11224. doi: 10.1038/ncomms11224. Nat Commun. 2016. PMID: 27091615 Free PMC article.
-
An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.J Virol. 2007 Apr;81(8):4033-43. doi: 10.1128/JVI.02588-06. Epub 2007 Feb 7. J Virol. 2007. PMID: 17287272 Free PMC article.
-
Genetic and structural determinants of virus neutralizing antibodies.Immunol Res. 2001;23(2-3):135-45. doi: 10.1385/IR:23:2-3:135. Immunol Res. 2001. PMID: 11444379 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources